Joleen Terese White - Publications

Affiliations: 
2002 Scripps Research Institute, La Jolla, La Jolla, CA, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 White JT, Crossman M, Subramanyam M. Incurred sample reproducibility and stability assessment in a cell-based drug concentration assay. Bioanalysis. 7: 1347-53. PMID 26110707 DOI: 10.4155/Bio.15.47  0.306
2014 van de Merbel N, Savoie N, Yadav M, Ohtsu Y, White J, Riccio MF, Dong K, de Vries R, Diancin J. Stability: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team. The Aaps Journal. 16: 392-9. PMID 24550081 DOI: 10.1208/S12248-014-9573-Z  0.309
2006 Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 13: 57-66. PMID 16911959 DOI: 10.1080/13506120600722449  0.683
2004 Hurshman AR, White JT, Powers ET, Kelly JW. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry. 43: 7365-81. PMID 15182180 DOI: 10.1021/Bi049621L  0.679
2003 Hammarström P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry. 42: 6656-63. PMID 12779320 DOI: 10.1021/Bi027319B  0.675
2001 White JT, Kelly JW. Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro. Proceedings of the National Academy of Sciences of the United States of America. 98: 13019-24. PMID 11687657 DOI: 10.1073/Pnas.241406698  0.513
2001 Jiang X, Smith CS, Petrassi HM, Hammarström P, White JT, Sacchettini JC, Kelly JW. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 40: 11442-52. PMID 11560492 DOI: 10.1021/Bi011194D  0.635
Show low-probability matches.